NCT06524375
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06524375
Title A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period (BRAVE)
Acronym BRAVE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Rocky Mountain Cancer Centers (Aurora) - USOR Aurora Colorado 80012-5405 United States Details
Cancer Specialists of North Florida Jacksonville Florida 32256-6932 United States Details
Fort Wayne Medical Oncology and Hematology, Inc Fort Wayne Indiana 46804 United States Details
Mission Blood and Cancer - MercyOne Cancer Center Des Moines Iowa 50314-3030 United States Details
American Oncology Partners of Maryland, PA Bethesda Maryland 20817-1915 United States Details
Dana-Farber Cancer Institute - Hematologic Oncology Treatment Center Boston Massachusetts 02215-5418 United States Details
Nebraska Cancer Specialists St Francis - Grand Island Grand Island Nebraska 68803 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130-2042 United States Details
Astera Cancer Care East Brunswick East Brunswick New Jersey 08816-4096 United States Details
San Juan Oncology Associates, PC Farmington New Mexico 87401 United States Details
Oncology Hematology Care Inc - Cincinnati - USOR Cincinnati Ohio 45236-2725 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401-6043 United States Details
Asante Rogue Regional Medical Center Medford Oregon 97504-8332 United States Details
Tennessee Oncology, PLLC - Chattanooga Chattanooga Tennessee 37404 United States Details
Tennessee Oncology - Midtown Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Oncology- Northeast Texas Tyler Texas 75702 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field